CME Activities

Please note – some of the CME activities below reference AZEDRA (iobenguane I-131).  This therapy is no longer FDA approved and no longer available for metastatic and unresectable pheochromocytoma and paraganglioma.  Learn more here. 

Think NENS Global Education Program for Primary Care Physician by INCA – Featuring Pheochromocytoma Module

Clinical Vignettes to Ask the Expert: Rare Cases of Pheochromocytoma & Paraganglioma

Cardiac Pheochromocytoma